Istari Oncology, Inc. logo

Istari Oncology, Inc.

Istari Oncology, is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors.

Istari was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center. In 2016, Duke University licensed a broad range of patents and patent applications to Istari Oncology and provided access to additional intellectual property created at Duke to continue clinical and commercial development of these technologies.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.istarioncology.com
Founded2014
Disease Focus
Development StageClinical
STOCK CODENon Listed
Address
6 Davis Drive,NC 027709
Research Triangle Park
United States
Email
Contact Number
+1 919-245-7662

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In 2017, Istari Oncology raised $5.1 Mn in two different funding rounds in a private equity offering.